Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective

Author:

Kaplan David E12,Serper Marina123,Kaushik Ankita4,Durkin Claire1,Raad Angie5,El-Moustaid Fadoua5,Smith Nathaniel5,Yehoshua Alon4

Affiliation:

1. Department of Medicine, Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

2. Gastroenterology Section, Philadelphia VA Medical Center, PA.

3. Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, PA.

4. Gilead Sciences Inc., Foster City, CA.

5. Maple Health Group, LLC, NY.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hepatitis C in Black Individuals in the US;JAMA;2023-12-12

2. Costs of treating multidrug-resistant TB in California in 2022;The International Journal of Tuberculosis and Lung Disease;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3